Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01077544
Title A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: child
Covered Countries NLD | ITA | GBR | FRA

Facility Status City State Zip Country Details
Novartis Investigative Site Bordeaux Aquitaine 33076 France Details
Novartis Investigative Site Lille cedex 59037 France Details
Novartis Investigative Site Paris 75571 France Details
Novartis Investigative Site Poitiers 86021 France Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Padova PD 35128 Italy Details
Novartis Investigative Site Roma RM 00161 Italy Details
Novartis Investigative Site Amsterdam 1081 HV Netherlands Details
Novartis Investigative Site Rotterdam 3015 CN Netherlands Details
Novartis Investigative Site West Midlands Birmingham B4 6NH United Kingdom Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
Novartis Investigative Site Bristol BS2 8BJ United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field